开发用于夏科-玛丽-病的基因疗法:进展和挑战
Marina Stavrou1, Alexia Kagiava1, Irene Sargiannidou1
1Neuroscience Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Regenerative medicine
|April 12, 2025
概括
基因治疗为Charcot-Marie-Tooth (CMT) 疾病,一种渐进的神经病变提供了新的希望. 虽然有希望,但在临床准备方面,必须克服交付,安全和可扩展性方面的挑战.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 查洛特-玛丽-牙 (CMT) 病是一组遗传性,渐进性神经病变.
- 目前对CMT的治疗仅限于症状治疗.
- 没有批准的疗法专门针对CMT的潜在原因.
研究的目的:
- 审查CMT基因疗法的最新进展.
- 突出基因沉默,替代和编辑策略的进展.
- 总结临床前的成功,并确定翻译方面的挑战.
主要方法:
- 对CMT的基因治疗方法的当前文献的综述.
- 对基因沉默,替代和编辑的临床前数据的分析.
- 对AAV载体和纳米粒子等传递技术的评估.
主要成果:
- 基因疗法策略对各种CMT类型显示有前途.
- AAV矢量和纳米粒子系统是领先的交付技术.
- 仍然存在重大挑战,包括血神经/大脑屏障的透,免疫性,毒性和可扩展性.
结论:
- 优化治疗交付对于临床准备至关重要.
- 提高安全概况和开发监测生物标志物是必不可少的.
- 推进CMT治疗需要解决这些翻译障碍.
相关概念视频
00:59Gene Therapy
25.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.0K
00:49What is Genetic Engineering?
72.8K
Overview
72.8K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K